KDM1A and liver cancer: Intriguingly, a significant decrease in the H3K4me2 level was observed during human liver cancer progression whereas substantially increased expression of LSD1 was previously reported; patients with higher expression of LSD1 or lower H3k4me2 marks exhibited poor clinical outcomes28–32.